Physician profile
Lawrence Lu
NPI 1508442146
$761.06
in general payments reported to CMS, 2019-2025
16 companies · $677 in 2025
The $677 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $84.09 · 2025: $677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679 · Education: $81.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.07 |
| Education | $81.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $178.73 | 2024-2025 | Veozah |
| Exact Sciences Corporation | $62.06 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $60.27 | 2024-2025 | Rexulti |
| Pfizer INC. | $51.09 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $49.64 | 2025 | Breztri, Airsupra |
| Amgen INC. | $47.74 | 2025 | Repatha, Otezla |
| Si-Bone, INC. | $38.12 | 2025 | |
| Axsome Therapeutics, INC. | $36.33 | 2025 | Auvelity |
| Abbvie INC. | $34.53 | 2025 | |
| Lundbeck LLC | $34.51 | 2025 | Rexulti |
| Globus Medical, INC. | $33.79 | 2025 | Senza |
| Glaxosmithkline, LLC. | $33.72 | 2025 | Shingrix |
| Lilly USA, LLC | $33.68 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Novo Nordisk INC | $32.65 | 2025 | Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.01 | 2025 | Xifaxan |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.19 | 2024 | Gardasil, Capvaxive, Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.